ScholarLens Back to search
2023•Unpublished venueOpen access

Supplementary Data from Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment

Hugues Sicotte, Krishna R. Kalari, Sisi Qin, Scott M. Dehm, Vipul Bhargava, Michael Gormley, Winston W. Tan, Jason P. Sinnwell, David W. Hillman, Ying Li, Peter T. Vedell, Rachel E. Carlson, Alan Haruo Bryce, Raphael E. Jimenez, Richard M. Weinshilboum, Manish Kohli, Liewei Wang

Open full text 0 citations

Abstract

Supplementary Data from Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment

About this research paper

What this paper is about

Supplementary Data from Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Supplementary Data from Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment

Key concepts: Abiraterone, Prednisone, Prostate cancer, Medicine, Oncology, Internal medicine, Cancer, Urology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Supplementary Data from Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment — Research Paper | ScholarLens